These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16387078)

  • 21. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
    Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
    Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric renal transplantation: single center experience.
    Mir S; Erdoğan H; Serdaroğlu E; Kabasakal C; Hoşcoşkun C
    Pediatr Transplant; 2005 Feb; 9(1):56-61. PubMed ID: 15667613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
    Hartmann A; Sagedal S; Hjelmesaeth J
    Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus antibody status and kidney transplantation.
    Terasaki PI; Yuge J; Cecka JM; Gjertson DW
    Clin Transpl; 1994; ():509-18. PubMed ID: 7547579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients.
    Costa C; Touscoz GA; Bergallo M; Terlizzi ME; Astegiano S; Sidoti F; Sinesi F; Segoloni GP; Cavallo R
    Clin Transplant; 2010; 24(4):488-92. PubMed ID: 19758268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.
    Heldal K; Hartmann A; Leivestad T; Svendsen MV; Foss A; Lien B; Midtvedt K
    Transplantation; 2009 Apr; 87(7):1045-51. PubMed ID: 19352126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients.
    Sadeghi M; Daniel V; Naujokat C; Schnitzler P; Schmidt J; Mehrabi A; Zeier M; Opelz G
    Transplantation; 2008 Jul; 86(2):275-85. PubMed ID: 18645491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for prevention of cytomegalovirus infection in renal transplant patients.
    Valenzuela M; Ortiz AM; Troncoso P; Vilches S
    Transplant Proc; 2009; 41(6):2673-5. PubMed ID: 19715999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk.
    Sagedal S; Rollag H; Hartmann A
    Clin Transplant; 2007; 21(3):309-13. PubMed ID: 17488378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection in renal transplant recipients.
    Carstens J; Andersen HK; Spencer E; Madsen M
    Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
    Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
    Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A; Lord H; Collette S; Morin M; Dandavino R
    Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
    Cinti P; Pretagostini R; Arpino A; Tamburro ML; Mengasini S; Lattanzi R; De Simone P; Berloco P; Molajoni ER
    Transplantation; 2005 May; 79(9):1154-6. PubMed ID: 15880060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.